Aqtual

Aqtual is a liquid biopsy startup. Aqtual's mission is to revolutionize chronic disease and oncology management by bridging the translational gap between breakthrough research and practical healthcare solutions. Through proprietary biochemistry, new technologies, and advanced data science, Aqtual is building a comprehensive catalog of disease-specific clinical features and developing highly accurate blood tests for disease detection, monitoring, and patient stratification in chronic inflammation and oncology.